Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela De Zio

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
<i>S</i>-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagySalvatore Rizza, Simone Cardaci, Costanza Montagna, et al.
Nature Neuroscience|December 15, 2010
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's diseaseMarcello D'Amelio, Virve Cavallucci, Silvia Middei, et al.
Frontiers in Immunology|April 2, 2020
Altered Tregs Differentiation and Impaired Autophagy Correlate to Atherosclerotic DiseaseSara Mandatori, Ilenia Pacella, Vincenzo Marzolla, et al.
Cell Death & Disease|July 26, 2023
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanomaTamara Bintener, Maria Pires Pacheco, Demetra Philippidou, et al.
Oncoimmunology|December 22, 2022
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockadeLoulieta Nazerai, Shona Caroline Willis, Patricio Yankilevich, et al.
Antioxidants & Redox Signaling|April 2, 2014
S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunctionCostanza Montagna, Giuseppina Di Giacomo, Salvatore Rizza, et al.
Cell Reports|January 19, 2023
GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylationSalvatore Rizza, Luca Di Leo, Chiara Pecorari, et al.
Journal for Immunotherapy of Cancer|March 3, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanomaAlex Frias, Luca Di Leo, Asier Antoranz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanomaLuca Di Leo, Chiara Pagliuca, Ali Kishk, et al.
Cellular and Molecular Life Sciences : CMLS|August 16, 2023
AMBRA1 phosphorylation by CDK1 and PLK1 regulates mitotic spindle orientationFiorella Faienza, Federica Polverino, Girish Rajendraprasad, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
<i>S</i>-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagySalvatore Rizza, Simone Cardaci, Costanza Montagna, et al.
Nature Neuroscience|December 15, 2010
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's diseaseMarcello D'Amelio, Virve Cavallucci, Silvia Middei, et al.
Frontiers in Immunology|April 2, 2020
Altered Tregs Differentiation and Impaired Autophagy Correlate to Atherosclerotic DiseaseSara Mandatori, Ilenia Pacella, Vincenzo Marzolla, et al.
Cell Death & Disease|July 26, 2023
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanomaTamara Bintener, Maria Pires Pacheco, Demetra Philippidou, et al.
Oncoimmunology|December 22, 2022
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockadeLoulieta Nazerai, Shona Caroline Willis, Patricio Yankilevich, et al.
Antioxidants & Redox Signaling|April 2, 2014
S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunctionCostanza Montagna, Giuseppina Di Giacomo, Salvatore Rizza, et al.
Cell Reports|January 19, 2023
GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylationSalvatore Rizza, Luca Di Leo, Chiara Pecorari, et al.
Journal for Immunotherapy of Cancer|March 3, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanomaAlex Frias, Luca Di Leo, Asier Antoranz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanomaLuca Di Leo, Chiara Pagliuca, Ali Kishk, et al.
Cellular and Molecular Life Sciences : CMLS|August 16, 2023
AMBRA1 phosphorylation by CDK1 and PLK1 regulates mitotic spindle orientationFiorella Faienza, Federica Polverino, Girish Rajendraprasad, et al.
Pageof 4